News
EVGN
0.7086
+2.19%
0.0152
Evogene Earnings Call: AI Momentum vs. Cash Strain
TipRanks · 1d ago
Evogene Files Secondary Offering Of 2,446,707 Shares By Selling Shareholder
Benzinga · 2d ago
Evogene Tightens Focus on AI Small-Molecule Platform as Q1 2026 Revenue Falls
TipRanks · 2d ago
Evogene reporta Q1 cont. ops. EPS (60c) vs. (26c) last year
TipRanks · 2d ago
Earnings Scheduled For May 20, 2026
Benzinga · 2d ago
Evogene misses Q1 estimates
Seeking Alpha · 2d ago
Evogene Q1 EPS $(0.60) Misses $(0.27) Estimate, Sales $334.000K Miss $350.000K Estimate
Benzinga · 2d ago
Evogene: Q1 Earnings Snapshot
Barchart · 2d ago
Here are the major earnings before the open Wednesday
Seeking Alpha · 2d ago
Evogene Q1 2026 Earnings Preview
Seeking Alpha · 3d ago
Evogene’s Ag Plenus, Bayer End Herbicide Collaboration as APTH1 Target Falls Short
TipRanks · 4d ago
Weekly Report: what happened at EVGN last week (0511-0515)?
Weekly Report · 4d ago
Evogene to Present at the 24th Schrödinger European User Group Meeting
PR Newswire · 05/12 12:00
Weekly Report: what happened at EVGN last week (0504-0508)?
Weekly Report · 05/11 10:15
Evogene Schedules First Quarter 2026 Financial Results Release
PR Newswire · 05/07 12:00
Weekly Report: what happened at EVGN last week (0427-0501)?
Weekly Report · 05/04 10:12
Weekly Report: what happened at EVGN last week (0420-0424)?
Weekly Report · 04/27 10:15
Weekly Report: what happened at EVGN last week (0413-0417)?
Weekly Report · 04/20 10:11
Evogene price target raised to $2.25 from $1.75 at Alliance Global
TipRanks · 04/13 14:21
Weekly Report: what happened at EVGN last week (0406-0410)?
Weekly Report · 04/13 10:15
More
Webull provides a variety of real-time EVGN stock news. You can receive the latest news about Evogene through multiple platforms. This information may help you make smarter investment decisions.
About EVGN
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.